Authors
Peter Aaby, Henrik Jensen, Badara Samb, Badara Cisse, Morten Sodemann, Marianne Jakobsen, Anja Poulsen, Amabelia Rodrigues, Ida Maria Lisse, Francois Simondon, Hilton Whittle
Publication date
2003/6/28
Journal
The Lancet
Volume
361
Issue
9376
Pages
2183-2188
Publisher
Elsevier
Description
Background
Females given high-titre measles vaccine (HTMV) have high mortality; diphtheria-tetanus-pertussis (DTP) vaccination might be associated with increased female mortality. We aimed to assess whether DTP or inactivated poliovirus (IPV) administered after HTMV was associated with increased female-male mortality ratio.
Methods
In three trials from West Africa, 2000 children were randomised to HTMV or control vaccine at 4–5 months of age; a second vaccination was given at age 9–10 months (standard measles vaccine). Children in high-titre groups were given IPV or DTP-IPV. Another 944 children received HTMV as routine vaccination in Senegal.
Findings
When we compared high-titre and control groups, no difference in mortality between the first and the second vaccination was noted. After the second vaccination, the female-male mortality ratio was 1·84 (95% CI 1·19–2·84) in children in the high-titre …
Total citations
200320042005200620072008200920102011201220132014201520162017201820192020202120222023202431311101061499178111413159101610895